earnings
MR
NASDAQ · MRVI
Maravai LifeSciences Holdings, Inc.
Healthcare · Biotechnology
$7.68
Down-$0.69 (-8.24%)
Updated Aug 29, 2026, 12:54 PM
SID Score
6.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.03B
- P/E ratio
- -4.43
- Dividend yield
- 0.00%
- 52-week range
- $2.28 – $9.42
- Volume
- 5.56M
- Avg. volume
- 1.5M
Price performance
MRVI price history
1M range · 21 trading sessions · Daily adjusted prices
MRVI closed at $7.68 after 21 trading sessions, up 16.89% for the selected period.
- Last close
- $7.68
- Period change
- +16.89%
- Period low
- $5.68
- Period high
- $9.00
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $8.12 | $8.175 | $7.645 | $7.68 | 5.56M |
| Aug 27, 2026 | $8.76 | $8.98 | $8.325 | $8.37 | 3.17M |
| Aug 26, 2026 | $8.85 | $9.42 | $8.68 | $8.90 | 5.54M |
| Aug 25, 2026 | $8.53 | $9.06 | $8.34 | $9.00 | 5.7M |
| Aug 24, 2026 | $8.59 | $8.615 | $8.13 | $8.43 | 6.97M |
| Aug 21, 2026 | $8.28 | $8.87 | $8.20 | $8.64 | 9.39M |
| Aug 20, 2026 | $7.44 | $8.3781 | $7.38 | $8.29 | 13.15M |
| Aug 19, 2026 | $6.717 | $7.70 | $6.717 | $7.22 | 15.14M |
| Aug 18, 2026 | $5.65 | $5.79 | $5.53 | $5.74 | 1.72M |
| Aug 17, 2026 | $5.66 | $5.745 | $5.5838 | $5.68 | 2.15M |
| Aug 14, 2026 | $5.72 | $5.82 | $5.55 | $5.70 | 2.38M |
| Aug 13, 2026 | $5.82 | $5.905 | $5.68 | $5.78 | 1.41M |
| Aug 12, 2026 | $5.78 | $5.915 | $5.665 | $5.78 | 1.74M |
| Aug 11, 2026 | $6.09 | $6.18 | $5.725 | $5.81 | 2.42M |
| Aug 10, 2026 | $6.12 | $6.35 | $5.96 | $6.07 | 2.24M |
| Aug 7, 2026 | $5.60 | $6.255 | $5.41 | $6.23 | 4.08M |
| Aug 6, 2026 | $6.42 | $6.45 | $6.155 | $6.25 | 1.47M |
| Aug 5, 2026 | $6.43 | $6.52 | $6.33 | $6.41 | 1.2M |
| Aug 4, 2026 | $6.43 | $6.49 | $6.31 | $6.43 | 1.61M |
| Aug 3, 2026 | $6.60 | $6.65 | $6.28 | $6.42 | 2.05M |
| Jul 31, 2026 | $6.76 | $6.77 | $6.45 | $6.57 | 1.09M |
Latest MRVI news
The latest Smart Investors Daily articles mentioning MRVI.
Stock researchResearch & News · SID Coverage
Loading stock research…